Literature DB >> 19915460

Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.

Giovanni Musso1, Roberto Gambino, Maurizio Cassader.   

Abstract

PURPOSE OF REVIEW: To examine the role of gut microbiota in the regulation of host energy homeostasis and its role in the pathogenesis of obesity, diabetes and nonalcoholic fatty liver disease (NAFLD). RECENT
FINDINGS: Experimental models highlight several mechanisms connecting gut microbiota to host energy metabolism: increased energy harvesting from the diet, regulation of appetite through gut peptide, secretion, regulation of tissue-free fatty acid composition and uptake, storage and oxidation, modulation of intestinal barrier by glucagon-like peptide-2 secretion, activation of innate immunity and hepatic fibrogenesis through the lipopolysaccharide (LPS)-toll-like receptor-4 axis.Gut microbiota manipulation through antibiotics, prebiotics and probiotics yields encouraging results for the treatment of obesity, diabetes and NAFLD in animal models, but data in humans are currently scarce.
SUMMARY: Gut microbiota manipulation yielded encouraging results for the treatment of different metabolic disorders in experimental models. However, changing intestinal microbiota may be more difficult in free-living individuals compared to standardized laboratory models, and its long-term consequences are unknown. To safely and effectively change human gut microflora, future research should highlight the complex hormonal, immunomodulatory and metabolic mechanisms underlying microbiota-host interactions in different tissues and candidate treatments should be evaluated in well designed trials with patient-oriented end-points.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19915460     DOI: 10.1097/MOL.0b013e3283347ebb

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  59 in total

Review 1.  Prebiotics: tools to manipulate the gut microbiome and metabolome.

Authors:  Fatima Enam; Thomas J Mansell
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 3.346

2.  Our unindicted coconspirators: human metabolism from a microbial perspective.

Authors:  Andrew L Goodman; Jeffrey I Gordon
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

Review 3.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

4.  Free fatty acid receptors: emerging targets for treatment of diabetes and its complications.

Authors:  Venkat Vangaveti; Venkatesh Shashidhar; Ghassan Jarrod; Bernhard T Baune; R Lee Kennedy
Journal:  Ther Adv Endocrinol Metab       Date:  2010-08       Impact factor: 3.565

5.  Fatty acid binding receptors in intestinal physiology and pathophysiology.

Authors:  Elke Kaemmerer; Patrick Plum; Christina Klaus; Ralf Weiskirchen; Christian Liedtke; Maximilian Adolf; Angela Schippers; Norbert Wagner; Andrea Reinartz; Nikolaus Gassler
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

Review 6.  Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training.

Authors:  Marc D Cook; Jacob M Allen; Brandt D Pence; Matthew A Wallig; H Rex Gaskins; Bryan A White; Jeffrey A Woods
Journal:  Immunol Cell Biol       Date:  2015-12-02       Impact factor: 5.126

7.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

Review 8.  The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.

Authors:  Gerwyn Morris; Michael Berk; Andre Carvalho; Javier R Caso; Yolanda Sanz; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

Review 9.  Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease.

Authors:  Pietro Vajro; Giulia Paolella; Alessio Fasano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-05       Impact factor: 2.839

Review 10.  Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.

Authors:  Victoria Menzies; Nancy Jallo; Patricia Kinser; Jo Lynne W Robins; Kyungeh An; Carolyn Driscoll; Angela Starkweather; Jasmohan S Bajaj; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2014-07-18       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.